ReviewFrontiers in pharmacology2022

Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics.

Hongjin Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.